HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jusan Yang Selected Research

Reactive Oxygen Species (Oxygen Radicals)

3/2003Genetic redox preconditioning differentially modulates AP-1 and NF kappa B responses following cardiac ischemia/reperfusion injury and protects against necrosis and apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jusan Yang Research Topics

Disease

1Hypertrophy
08/2006
1Cardiomegaly (Heart Hypertrophy)
08/2006
1Infarction (Infarctions)
03/2003
1Ischemia
03/2003
1Reperfusion Injury
03/2003
1Necrosis
03/2003
1Hypoxia (Hypoxemia)
12/2002
1Infections
12/2002
1Wounds and Injuries (Trauma)
12/2002

Drug/Important Bio-Agent (IBA)

1Angiotensin IIIBA
08/2006
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
08/2006
1NADPH Oxidases (NAD(P)H oxidase)IBA
08/2006
1Small Interfering RNA (siRNA)IBA
08/2006
1Superoxides (Superoxide)IBA
08/2006
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
03/2003
1Creatine Kinase (Creatine Phosphokinase)IBA
03/2003
1Malondialdehyde (Propanedial)IBA
03/2003
1NF-kappa B (NF-kB)IBA
03/2003
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2003
1Serine (L-Serine)FDA Link
12/2002
1NF-KappaB Inhibitor alphaIBA
12/2002
1Messenger RNA (mRNA)IBA
12/2002
1pervanadateIBA
12/2002
1Transcription Factors (Transcription Factor)IBA
12/2002
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2002
1Tyrosine (L-Tyrosine)FDA Link
12/2002